Kindred Healthcare Inc. (KND) Financials Nov 17, 2
Post# of 250602
Posted On: 11/17/2014 11:01:31 PM
Kindred Healthcare Inc. (KND) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kindred Healthcare Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.27B 4.36B 5.52B 6.18B 4.9B
Cost of Goods Sold (COGS) incl. D&A 4.18B 3.92B 5.34B 5.97B 4.78B
COGS excluding D&A 4.05B 3.8B 5.17B 5.76B 4.59B
Depreciation & Amortization Expense 126.4M 121.55M 165.59M 201.48M 182.39M
Depreciation 124.8M 120.3M 152.2M 179.1M 135.2M
Amortization of Intangibles 1.6M 1.25M 13.39M 22.38M 47.19M
Gross Income 93.68M 441.65M 186M 215.83M 123.84M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - - - -
Research & Development - - - - -
Other SG&A - - - - -
Other Operating Expense 0 357.37M 0 0 0
Unusual Expense (11.51M) (11.42M) 179.18M 113.06M 79.29M
EBIT after Unusual Expense 11.51M 11.42M (179.18M) (113.06M) (79.29M)
Non Operating Income/Expense 0 0 9.69M 10.81M 1.44M
Non-Operating Interest Income 4.41M 1.25M 1.03M 1.05M 4.05M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 7.88M 7.09M 80.92M 107.9M 108.05M
Gross Interest Expense 10.08M 8.39M 82.42M 110.3M 108.15M
Interest Capitalized 2.2M 1.3M 1.5M 2.4M 100,000
Pretax Income 101.73M 89.85M (63.38M) 6.74M (58.02M)
Income Tax 39.12M 33.71M (7.1M) 39.11M (13.2M)
Income Tax - Current Domestic 27.47M 14.85M (6.55M) 51.49M 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 11.64M 18.85M (553,000) (12.38M) (13.2M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (701,000) (1.02M) 0 0 0
Consolidated Net Income 61.91M 55.13M (56.27M) (32.37M) (44.81M)
Minority Interest Expense 0 0 (238,000) 1.04M 3.66M
Net Income 61.91M 55.13M (56.03M) (33.41M) (48.47M)
Extraordinaries & Discontinued Operations (22.5M) 345,000 2.55M (6.95M) (120.02M)
Extra Items & Gain/Loss Sale Of Assets (23.43M) (453,000) 0 (4.75M) (83.89M)
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 931,000 798,000 2.55M (2.21M) (36.14M)
Net Income After Extraordinaries 39.41M 55.47M (53.48M) (40.37M) (168.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 61.91M 55.13M (56.03M) (33.41M) (48.47M)
EPS (Basic) 1.64 1.44 (1.16) (0.69) (1.62)
Basic Shares Outstanding 38.34M 38.74M 46.28M 51.66M 52.25M
EPS (Diluted) 1.63 1.44 (1.16) (0.69) (1.62)
Diluted Shares Outstanding 38.5M 38.95M 46.28M 51.66M 52.25M
EBITDA 220.09M 205.83M 351.6M 417.31M 306.22M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kindred Healthcare Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.27B 4.36B 5.52B 6.18B 4.9B
Cost of Goods Sold (COGS) incl. D&A 4.18B 3.92B 5.34B 5.97B 4.78B
COGS excluding D&A 4.05B 3.8B 5.17B 5.76B 4.59B
Depreciation & Amortization Expense 126.4M 121.55M 165.59M 201.48M 182.39M
Depreciation 124.8M 120.3M 152.2M 179.1M 135.2M
Amortization of Intangibles 1.6M 1.25M 13.39M 22.38M 47.19M
Gross Income 93.68M 441.65M 186M 215.83M 123.84M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - - - -
Research & Development - - - - -
Other SG&A - - - - -
Other Operating Expense 0 357.37M 0 0 0
Unusual Expense (11.51M) (11.42M) 179.18M 113.06M 79.29M
EBIT after Unusual Expense 11.51M 11.42M (179.18M) (113.06M) (79.29M)
Non Operating Income/Expense 0 0 9.69M 10.81M 1.44M
Non-Operating Interest Income 4.41M 1.25M 1.03M 1.05M 4.05M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 7.88M 7.09M 80.92M 107.9M 108.05M
Gross Interest Expense 10.08M 8.39M 82.42M 110.3M 108.15M
Interest Capitalized 2.2M 1.3M 1.5M 2.4M 100,000
Pretax Income 101.73M 89.85M (63.38M) 6.74M (58.02M)
Income Tax 39.12M 33.71M (7.1M) 39.11M (13.2M)
Income Tax - Current Domestic 27.47M 14.85M (6.55M) 51.49M 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 11.64M 18.85M (553,000) (12.38M) (13.2M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (701,000) (1.02M) 0 0 0
Consolidated Net Income 61.91M 55.13M (56.27M) (32.37M) (44.81M)
Minority Interest Expense 0 0 (238,000) 1.04M 3.66M
Net Income 61.91M 55.13M (56.03M) (33.41M) (48.47M)
Extraordinaries & Discontinued Operations (22.5M) 345,000 2.55M (6.95M) (120.02M)
Extra Items & Gain/Loss Sale Of Assets (23.43M) (453,000) 0 (4.75M) (83.89M)
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 931,000 798,000 2.55M (2.21M) (36.14M)
Net Income After Extraordinaries 39.41M 55.47M (53.48M) (40.37M) (168.49M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 61.91M 55.13M (56.03M) (33.41M) (48.47M)
EPS (Basic) 1.64 1.44 (1.16) (0.69) (1.62)
Basic Shares Outstanding 38.34M 38.74M 46.28M 51.66M 52.25M
EPS (Diluted) 1.63 1.44 (1.16) (0.69) (1.62)
Diluted Shares Outstanding 38.5M 38.95M 46.28M 51.66M 52.25M
EBITDA 220.09M 205.83M 351.6M 417.31M 306.22M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼